Accurate expression of PD‐L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry

The percentage of programmed death ligand 1 (PD‐L1) positivity in cancer cells, named as the tumor proportion score, is considered to be a predictive biomarker for anti‐PD‐1/PD‐L1 therapy in lung cancer. PD‐L1 is expressed on not only cancer cells but also on immune cells, including macrophages. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinchi, Yusuke, Komohara, Yoshihiro, Yonemitsu, Kimihiro, Sato, Kensaku, Ohnishi, Koji, Saito, Yoichi, Fujiwara, Yukio, Mori, Takeshi, Shiraishi, Kenji, Ikeda, Koei, Suzuki, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726681/
https://www.ncbi.nlm.nih.gov/pubmed/31294893
http://dx.doi.org/10.1111/cas.14128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726681/
https://www.ncbi.nlm.nih.gov/pubmed/31294893
http://dx.doi.org/10.1111/cas.14128

Ejemplares similares